Inovio Pharmaceuticals Inc vs iShares TIPS Bond ETF — how do they compare? Inovio Pharmaceuticals Inc trades at $1.1 (market cap $89.27M), while iShares TIPS Bond ETF trades at $107.93. Which is the better fit depends on your goals.
| INO | TIP | |
|---|---|---|
Market Cap | $89.27M | — |
Sector | Health | Fixed Income |
52-Week High | $2.87 | $112.20 |
52-Week Low | $1.05 | $107.91 |
Enterprise Value | $60.28M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TIP trades at $108.05, down 0.2% today, with technical indicators showing a bearish bias from moving averages but neutral oscillators. The stock lacks disclosed valuation metrics like P/E and P/S, and recent news highlights bond market volatility and Federal Reserve uncertainty influencing investor sentiment. Dividend payments are scheduled for 2026, providing income visibility.
Outlook is cautious due to bearish technical signals and macroeconomic risks from potential Fed rate hikes. Investment opportunities include dividend income, but risks involve market volatility and lack of current fundamental data. Investors should await earnings reports for clarity on financial health.
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →